Copyright
©2013 Baishideng Publishing Group Co.
World J Ophthalmol. Aug 12, 2013; 3(3): 20-31
Published online Aug 12, 2013. doi: 10.5318/wjo.v3.i3.20
Published online Aug 12, 2013. doi: 10.5318/wjo.v3.i3.20
Figure 6 Collagen cross-linking.
A, B: Accelerated corneal collagen cross-linking (A) equipment (B) and riboflavin instillation, collagen cross-linking (CXL) treatment could be decreased to 3 min with Ultraviolet-light intensity of 30 mW/cm2 achieving the same energy on cornea of conventional CXL of 5 J/cm2; C: Right eye three days after accelerated cross-linking showing corneal epithelium recovery; D: Left eye also after three days following accelerated CXL.
- Citation: Jaimes M, Ramirez-Miranda A, Graue-Hernández EO, Navas A. Keratoconus therapeutics advances. World J Ophthalmol 2013; 3(3): 20-31
- URL: https://www.wjgnet.com/2218-6239/full/v3/i3/20.htm
- DOI: https://dx.doi.org/10.5318/wjo.v3.i3.20